Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
8.56%
operating margin TTM
3.41%
revenue TTM
610.82 Million
revenue per share TTM
16.25$
valuation ratios | |
|---|---|
| pe ratio | 29.99 |
| peg ratio | 1.66 |
| price to book ratio | 0.90 |
| price to sales ratio | 2.57 |
| enterprise value multiple | 32.26 |
| price fair value | 0.90 |
profitability ratios | |
|---|---|
| gross profit margin | 48.47% |
| operating profit margin | 3.41% |
| pretax profit margin | 13.14% |
| net profit margin | 8.56% |
| return on assets | 2.49% |
| return on equity | 3.05% |
| return on capital employed | 1.19% |
liquidity ratio | |
|---|---|
| current ratio | 3.61 |
| quick ratio | 3.04 |
| cash ratio | 1.00 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 230.57 |
| operating cycle | 333.52 |
| days of payables outstanding | 50.28 |
| cash conversion cycle | 283.24 |
| receivables turnover | 3.55 |
| payables turnover | 7.26 |
| inventory turnover | 1.58 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.97 |
| cash per share | 23.40 |
| operating cash flow per share | 3.47 |
| free cash flow operating cash flow ratio | 0.57 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 2.32 |
Frequently Asked Questions
When was the last time Taro Pharmaceutical Industries Ltd. (NYSE:TARO) reported earnings?
Taro Pharmaceutical Industries Ltd. (TARO) published its most recent earnings results on 21-05-2024.
What is Taro Pharmaceutical Industries Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Taro Pharmaceutical Industries Ltd. (NYSE:TARO)'s trailing twelve months ROE is 3.05%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Taro Pharmaceutical Industries Ltd. (TARO) currently has a ROA of 2.49%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TARO's net profit margin stand at?
TARO reported a profit margin of 8.56% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TARO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.61 in the most recent quarter. The quick ratio stood at 3.04, with a Debt/Eq ratio of 0.00.